Merck & Co., Inc.
MRK · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $17,276,000 | $15,806,000 | $15,529,000 | $15,624,000 |
| % Growth | 9.3% | 1.8% | -0.6% | – |
| Cost of Goods Sold | $3,124,000 | $3,557,000 | $3,419,000 | $3,828,000 |
| Gross Profit | $14,152,000 | $12,249,000 | $12,110,000 | $11,796,000 |
| % Margin | 81.9% | 77.5% | 78% | 75.5% |
| R&D Expenses | $3,997,000 | $4,048,000 | $3,621,000 | $4,584,000 |
| G&A Expenses | $0 | $0 | $0 | $291,000 |
| SG&A Expenses | $2,599,000 | $2,649,000 | $2,552,000 | $2,691,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2,400,000 |
| Other Operating Expenses | $0 | $0 | $0 | $173,000 |
| Operating Expenses | $6,596,000 | $6,697,000 | $6,173,000 | $7,448,000 |
| Operating Income | $7,556,000 | $5,552,000 | $5,937,000 | $4,348,000 |
| % Margin | 43.7% | 35.1% | 38.2% | 27.8% |
| Other Income/Exp. Net | -$811,000 | -$553,000 | -$34,000 | -$178,000 |
| Pre-Tax Income | $6,745,000 | $4,999,000 | $5,903,000 | $4,170,000 |
| Tax Expense | $958,000 | $571,000 | $818,000 | $426,000 |
| Net Income | $5,785,000 | $4,427,000 | $5,079,000 | $3,743,000 |
| % Margin | 33.5% | 28% | 32.7% | 24% |
| EPS | 2.32 | 1.77 | 2.02 | 1.48 |
| % Growth | 31.1% | -12.4% | 36.5% | – |
| EPS Diluted | 2.32 | 1.76 | 2.01 | 1.48 |
| Weighted Avg Shares Out | 2,498,000 | 2,503,140 | 2,516,082 | 2,541,000 |
| Weighted Avg Shares Out Dil | 2,498,000 | 2,513,000 | 2,531,000 | 2,541,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $69,000 | $109,000 | $146,000 |
| Interest Expense | $238,000 | $305,000 | $313,000 | $328,000 |
| Depreciation & Amortization | $1,154,000 | $1,119,000 | $1,099,000 | $1,197,000 |
| EBITDA | $8,137,000 | $6,423,000 | $7,315,000 | $5,695,000 |
| % Margin | 47.1% | 40.6% | 47.1% | 36.5% |